Additionally, the adjunctive probiotic Lactobacillus rhamnosus probio-M9 was determined to enhance the effect of anti-PD-1 antitumor therapy by repairing antibiotic-disrupted GM in mouse models of colorectal cancer (116). The gene discussed is PDCD1; the disease is colorectal cancer.